Neurology News

The likelihood that opioid treatment for common neurological conditions was initiated appeared to decrease with greater access to neurologists or other specialists who offered alternative pain treatment.

Individuals with Parkinson’s disease and their caregivers had higher satisfaction with usual care than previously thought, according to findings presented at the American Neurological Association annual meeting.

Anti-inflammatories and antidepressants may help prevent neurocognitive worsening among people with HIV, according to findings presented at the American Neurological Association annual meeting.

Use of a transitions of care clinic may reduce 30-day stroke readmissions, according to findings presented at the American Neurological Association annual meeting.

Long-term adjunctive perampanel treatment was efficacious and generally well tolerated among older patients with focal-onset seizures, according to findings presented at the annual meeting of the American Neurological Association.

In this video from the Annual Meeting of the American Neurological Association, Justin C. McArthur, MBBS, MPH, discussed the Presidential Symposium, “COVID-19 Pandemic: Population Impact and Responses, and Neurological Complications.”

Many patients who experience migraine or headaches either hesitated or never sought medical care for their condition, according to data from two studies presented during the PAINWeek National Conference.

Mindfulness-based stress reduction appeared to safely treat total migraine burden with long-lasting effects, according to findings presented at the annual meeting of the American Neurological Association.

Some patients with COVID-19 may experience isolated encephalopathy that cannot be explained by concurrent medical problems typically observed among these patients.

The FDA has granted 510(k) clearance to Siemens Medical Solutions Inc. for the Siemens Naeotom Alpha, a new advancement in diagnostic CT imaging, according to a company press release.